Article
GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.
Cancer epidemiology - 1 Oct 2016
Weich Natalia, Ferri Cristian, Moiraghi Beatriz, Bengió Raquel, Giere Isabel, Pavlovsky Carolina, Larripa Irene B, Fundia Ariela F
Abstract excerpt
BACKGROUND: Chronic myeloid leukemia (CML) is associated to the BCR-ABL1 oncogene and can successfully be treated with tyrosine kinase inhibitors (TKIs). However, it remains still under investigation which molecular factors may influence CML risk or varying responses to TKIs. The aim of this study was to assess the role of Glutathione-S-transferases (GSTs) genetic polymorphisms in CML susceptibility and TKI...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
